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Background
Adherence is one of the main determinants of PrEP effi-
cacy. Most PrEP studies applied subjective adherence
measures, which often produce overestimates and proble-
matic efficacy data interpretation; creating a need for
more objective measures. This study examines self-
reported adherence to oral PrEP compared to Medical
Events Monitoring System (MEMS).
Methods
Seventy-two HIV-uninfected partners (50% women) in
Uganda were randomized to daily or intermittent (Mon-
day, Friday and within 2 hours after sex, not exceeding 1
dose/day) oral emtricitabine/tenofovir or placebo in a
2:1:2:1 ratio for four months. Adherence was assessed
monthly by MEMS and self-reported taken or missed
doses by timeline follow-back calendar. MEMS data was
adjusted for extra openings without pill removal and
removal of multiple pills. Non-fixed days within intermit-
tent regimen were classified as adherent/non-adherent
based on self-reported sex by SMS. Adherence rates by
taken/missed doses were compared to raw MEMS data
using Spearman correlation.
Results
Treatment and placebo groups were combined since
adherence rates were similar. Daily raw MEMS adherence
rate was significantly higher than fixed Intermittent rate
(p=0.04) and post-coital dosing rate (p<0.0001). Raw
MEMS data for daily and fixed intermittent dosing,
poorly correlated with self-reported taken doses (r=0.14,
p=0.42 and r=0.01, p=0.94, respectively) and missed
doses (r=0.30, p=0.08 and r=0.07, p=0.69, respectively).
Self-reported daily adherence had high sensitivity but
only fair positive predictive value (PPV) and very poor
specificity. Self-reported adherence to intermittent fixed
dosing had fair sensitivity, PPV and negative predictive
value (NPV), but poor specificity. Self-reported adher-
ence to post-coital dosing had very good sensitivity and
NPV but poor specificity.
Conclusion
Median adherence for daily and intermittent fixed PrEP
was high by objective and subjective measures, but poorly
correlated. Adherence to post-coital dosing was poor and
likely overestimated by self-report (possibly reflecting
technical challenges of SMS). Self-reported adherence
measures were highly sensitive but poorly specific.
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